	Cervical carcinoma
Antigen processing machinery
ERAP1
	HLA class I expression
ERAP 1
ERAP 1 loss
HLA class I
expression
defective expression
TAP
APM components
significant association
cervical carcinoma
APM defects
tumour
independent prognostic parameter
normal expression
loss
ERAP 1 down-regulation
immunohistochemical
clinicopathological parameters
heavy chains
patients
tumour cells
cases
independent predictor
cervical cancer
study
DFS
expression data
TAP 2
cervical carcinoma patients
internal positive control
prognostic parameters
specific HPV status
Stromal cells
positive
human carcinoma
ERAP
survival
LMP 10
partial
components
invasion
LMP 2
down-regulation
scores
APM
previous reports
LMP 7

